Currently, Akebia Therapeutics, Inc. (AKBA) has a trading volume of 0.28 million shares and an average trading volume of 0.56 million shares. The volume of the particular stock is the shares bought and sold in a single trading day. The average volume of a stock suggests the liquidity of a particular company. If the average volume is low then the liquidity is low which means it is hard to buy or sell the stock as there are fewer buyers or sellers of the stock.
When applying indicators for technical analysis, traders and investors might want to examine the ATR or Average True Range. The current 14-day ATR for Akebia Therapeutics, Inc. (AKBA) is currently sitting at 0.44. The ATR basically measures the volatility of a stock on a day-to-day basis. The ATR is not considered a directional indicator, but it may reflect the strength of a particular move.
Analysts contributed current consensus rating at 2.00. This rating scales between 1 and 5. A rating of 1 or 2 would be suggesting a Buy. Analysts offer the company with a rating of 3 would be a sign of a Hold recommendation. 4 or 5 would b a Sell.
Akebia Therapeutics, Inc. (AKBA) stock remained 2.53% volatile for the week and 3.01% for the month. The company Return on Investment (ROI) is at -200.40%. The price to Free Cash Flow ratio is 21.47. The relative strength index (RSI) of the stock is located at 50.31.
In recent trade check out, shares of Akebia Therapeutics, Inc. (AKBA) are at -17.65% from the 52-week high, and are keeping their distance at 90.22% from 52-week low. Currently, the company ROA is -66.90%. Currently AKBA hold up 45.86 million outstanding shares and 35.08 million shares are floated in market.
Akebia Therapeutics, Inc. (AKBA) produced a gain of 4.29% to record the finishing price at $13.62 on Tuesday. AKBA recognized downfall move of -0.99% over prior week however the stock price shaped 25.46% so far this year — still in positive area. The stock gained around 48.24% in last one year. AKBA, a “Healthcare stock” with an industry focus on “Biotechnology”.
Akebia Therapeutics, Inc. (AKBA) is currently moving with a distance of approximately 25.04% from the 200 day simple moving average and sited a distance of 0.26% from its 20 days moving average and isolated downward from 50 days moving average with -3.31%.